News

Particle Sciences said that MRT technology combines a high shear, high pressure impinging jet processor with expert process development to generate results in bottom-up nanoparticle creation and continuous

Reportedly, Illumina had introduced the BeadXpress system in 2007 with Research Use Only kits for custom genotyping, gene expression, methylation and protein analysis. Since then it has been

Osiris Therapeutics is developing Prochymal in partnership with the Juvenile Diabetes Research Foundation (JDRF) as a treatment for patients with newly diagnosed type 1 diabetes mellitus. Prochymal, a

Vetter will fill early-stage, high-value biopharmaceuticals at its Chicago facility; Sentry will label, package and ship the clinical supplies from its site in Indianapolis, Indiana. The collaboration will

Under the agreement, Actavis will develop, obtain US FDA approval and supply the products, which Sagent will market in the US. Jeffrey Yordon, CEO, founder and chairman of

PPD is expecting to offer medical information call center support, adverse event capture, safety case processing and reporting, and periodic report writing services from Bulgaria. Sofia is expected

The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150mg (3ml) of

The study was a randomised, double-blind, placebo controlled trial conducted at 13 centers in the US in patients with genotype 1 chronic hepatitis C, 35% of whom had

PerkinElmer claimed that the Prenatal BoBs assay is the first IVD product from the BACs-on-Beads multiplexed bead-based technology product family. The assay is a novel solution for IVD